Technical Analysis for MYO - Myomo Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 0.41% | |
Wide Bands | Range Expansion | 0.41% | |
Gapped Up | Strength | 0.41% | |
50 DMA Resistance | Bearish | 2.93% | |
NR7 | Range Contraction | 2.93% | |
Inside Day | Range Contraction | 2.93% | |
Wide Bands | Range Expansion | 2.93% | |
50 DMA Resistance | Bearish | 7.12% | |
20 DMA Support | Bullish | 7.12% | |
Wide Bands | Range Expansion | 7.12% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 21 hours ago |
Up 10% | about 23 hours ago |
Up 1 ATR | about 23 hours ago |
2x Volume Pace | about 24 hours ago |
1.5x Volume Pace | about 24 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 03/07/2024
Myomo Inc. Description
Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Organ Systems Disability Robotics Neurological Disorders Stroke Multiple Sclerosis Amyotrophic Lateral Sclerosis Prosthetics Urological Disorders Nerve Orthopedics Podiatry Spinal Cord Skeletal System Neurotrauma
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.5799 |
52 Week Low | 0.371 |
Average Volume | 429,637 |
200-Day Moving Average | 2.13 |
50-Day Moving Average | 3.60 |
20-Day Moving Average | 3.36 |
10-Day Moving Average | 3.58 |
Average True Range | 0.39 |
RSI (14) | 53.27 |
ADX | 20.87 |
+DI | 27.08 |
-DI | 23.93 |
Chandelier Exit (Long, 3 ATRs) | 3.02 |
Chandelier Exit (Short, 3 ATRs) | 3.86 |
Upper Bollinger Bands | 4.14 |
Lower Bollinger Band | 2.58 |
Percent B (%b) | 0.7 |
BandWidth | 46.54 |
MACD Line | 0.04 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0402 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.21 | ||||
Resistance 3 (R3) | 4.27 | 4.15 | 4.12 | ||
Resistance 2 (R2) | 4.15 | 4.01 | 4.12 | 4.09 | |
Resistance 1 (R1) | 3.91 | 3.93 | 3.85 | 3.85 | 4.06 |
Pivot Point | 3.79 | 3.79 | 3.76 | 3.76 | 3.79 |
Support 1 (S1) | 3.55 | 3.65 | 3.49 | 3.49 | 3.28 |
Support 2 (S2) | 3.43 | 3.57 | 3.40 | 3.25 | |
Support 3 (S3) | 3.19 | 3.43 | 3.22 | ||
Support 4 (S4) | 3.13 |